3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis

NCT06903884 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Vernal Keratoconjunctivitis

Interventions

DRUG: 3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion
DRUG: 0.1% Cyclosporin A cationic ophthalmic emulsion

Sponsor

The University of Hong Kong